aluates Reports

$ 0.0

Automative

Global Oral Proteins and Peptides Market Research Report 2025

Published Date: March 2025

Report Code: QYRE-Auto-32T9537

Global Oral Proteins and Peptides Market Insights and Forecast to 2028

BUY CHAPTERS

Global Oral Proteins and Peptides Market Research Report 2025

Code: QYRE-Auto-32T9537

Report

March 2025

Pages:69

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novo Nordisk

Novartis

Synergy Pharmaceuticals （Salix）

Ironwood & Allergan

Chiasma (Amryt Pharma)

Oral Proteins and Peptides Market Size

The global market for Oral Proteins and Peptides was valued at US$ 3370 million in the year 2024 and is projected to reach a revised size of US$ 8885 million by 2031, growing at a CAGR of 15.1% during the forecast period.

Oral Proteins and Peptides Market

Polypeptide and protein drugs refer to the biological drugs of polypeptide and protein substances used for prevention,treatment and diagnosis.Polypeptide is a compound formed by linking α-amino acids together with a peptide chain,and it is also an intermediate product of proteolysis.N polypeptide chains are entangled in a certain spatial structure to form a protein.The hydrolysis of macromolecular proteins produces polypeptides.Such drugs are biochemical preparations and have relatively strict requirements on storage and transportation environment.The Oral Proteins and Peptides industry can be broken down into several segments, Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide, etc.Across the world, the major players cover Ironwood & Allergan (AbbVie), Novo Nordisk, Synergy Pharmaceuticals (Salix), Novartis, Chiasma (Amryt Pharma), etc.

Ironwood & Allergan is one of the most important global manufacturers of oral proteins and peptides, other key manufacturers include Novo Nordisk. North America is the largest market, occupied for over 60%. In terms of type, insulin is the largest segment, with a share of over 60%. And in terms of application, gastric & digestive disorders and bone diseases segment holds the most share.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Proteins and Peptides, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Proteins and Peptides.

The Oral Proteins and Peptides market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Proteins and Peptides market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oral Proteins and Peptides manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oral Proteins and Peptides Market Report

Report Metric	Details
Report Name	Oral Proteins and Peptides Market
Accounted market size in year	US$ 3370 million
Forecasted market size in 2031	US$ 8885 million
CAGR	15.1%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Linaclotide Insulin Plecanatide Cyclosporine Octreotide
Segment by Application	Gastric & Digestive Disorders Bone Diseases Diabetes Hormonal Disorders
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Ironwood & Allergan, Novo Nordisk, Synergy Pharmaceuticals （Salix）, Novartis, Chiasma (Amryt Pharma)
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Oral Proteins and Peptides manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Oral Proteins and Peptides in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Oral Proteins and Peptides Market growing?

Ans: The Oral Proteins and Peptides Market witnessing a CAGR of 15.1% during the forecast period 2025-2031.

What is the Oral Proteins and Peptides Market size in 2031?

Ans: The Oral Proteins and Peptides Market size in 2031 will be US$ 8885 million.

What is the Oral Proteins and Peptides Market share by region?

Ans: North America is the largest market, occupied for over 60%.

What is the Oral Proteins and Peptides Market share by type?

Ans: In terms of type, insulin is the largest segment, with a share of over 60%.

Who are the main players in the Oral Proteins and Peptides Market report?

Ans: The main players in the Oral Proteins and Peptides Market are Ironwood & Allergan, Novo Nordisk, Synergy Pharmaceuticals （Salix）, Novartis, Chiasma (Amryt Pharma)

What are the Application segmentation covered in the Oral Proteins and Peptides Market report?

Ans: The Applications covered in the Oral Proteins and Peptides Market report are Gastric & Digestive Disorders, Bone Diseases, Diabetes, Hormonal Disorders

What are the Type segmentation covered in the Oral Proteins and Peptides Market report?

Ans: The Types covered in the Oral Proteins and Peptides Market report are Linaclotide, Insulin, Plecanatide, Cyclosporine, Octreotide

Recommended Reports

Peptide Drug Market

Oral Drug Markets

Protein & Peptide Supplements

Market trends :

Topic	Trends
Global	the global oral proteins and peptides market is experiencing rapid growth driven by increasing demand for oral biologics, technological advancements, and expanding applications in chronic disease management.
Type	Linaclotide - linaclotide adoption is rising for gastrointestinal disorders due to improved patient compliance and efficacy in oral formulations. Insulin - oral insulin leads the market with significant advancements in delivery technologies, addressing the growing diabetes population. Plecanatide - plecanatide is gaining traction in the treatment of chronic idiopathic constipation, supported by favorable clinical outcomes. Cyclosporine - oral cyclosporine is being explored for expanded indications, leveraging its immunomodulatory properties in new therapeutic areas. Octreotide - oral octreotide is seeing increased adoption for hormonal disorders, offering a non-invasive alternative to injectable therapies.
Application	Gastric & Digestive Disorders - oral peptides are increasingly used for gastric and digestive disorders, driven by patient preference for non-injectable therapies. Bone Diseases - bone disease applications are expanding as oral peptide therapies demonstrate efficacy in improving bone health and patient outcomes. Diabetes - diabetes remains the largest application segment, with oral insulin innovations addressing the global rise in diabetes prevalence. Hormonal Disorders - oral peptide therapies for hormonal disorders are gaining momentum due to improved delivery and patient adherence.
Company	Ironwood & Allergan - ironwood & allergan maintain a leading position in oral peptide therapeutics, leveraging established products and ongoing innovation to strengthen market presence. Novo Nordisk - novo nordisk is capitalizing on the expanding oral insulin segment, focusing on innovative delivery technologies to address diabetes management. Synergy Pharmaceuticals （Salix） - synergy pharmaceuticals (salix) continues to expand its portfolio in gastrointestinal peptide therapies, targeting unmet needs in digestive disorders. Novartis - novartis is advancing its oral peptide pipeline with a focus on novel formulations and indications to broaden therapeutic reach. Chiasma (Amryt Pharma) - chiasma (amryt pharma) is driving growth through commercialization of oral octreotide, enhancing treatment options for hormonal disorders.
Region	North America - north america dominates the market with over 60% share, driven by high adoption rates and strong presence of key players. EMEA - emea is witnessing steady growth in oral peptide adoption, supported by regulatory approvals and expanding therapeutic indications. APAC - apac is emerging as a high-growth region for oral proteins and peptides, fueled by rising healthcare investments and disease prevalence. LATAM - latam shows increasing uptake of oral peptide therapies, supported by improving healthcare infrastructure and access to innovative treatments.

1 Oral Proteins and Peptides Market Overview

1.1 Product Definition

1.2 Oral Proteins and Peptides by Type

1.2.1 Global Oral Proteins and Peptides Market Value Comparison by Type (2024 VS 2031)

1.2.2 Linaclotide

1.2.3 Insulin

1.2.4 Plecanatide

1.2.5 Cyclosporine

1.2.6 Octreotide

1.3 Oral Proteins and Peptides by Application

1.3.1 Global Oral Proteins and Peptides Market Value by Application (2024 VS 2031)

1.3.2 Gastric & Digestive Disorders

1.3.3 Bone Diseases

1.3.4 Diabetes

1.3.5 Hormonal Disorders

1.4 Global Oral Proteins and Peptides Market Size Estimates and Forecasts

1.4.1 Global Oral Proteins and Peptides Revenue 2020-2031

1.4.2 Global Oral Proteins and Peptides Sales 2020-2031

1.4.3 Global Oral Proteins and Peptides Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Oral Proteins and Peptides Market Competition by Manufacturers

2.1 Global Oral Proteins and Peptides Sales Market Share by Manufacturers (2020-2025)

2.2 Global Oral Proteins and Peptides Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Oral Proteins and Peptides Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Oral Proteins and Peptides, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Oral Proteins and Peptides, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Oral Proteins and Peptides, Product Type & Application

2.7 Global Key Manufacturers of Oral Proteins and Peptides, Date of Enter into This Industry

2.8 Global Oral Proteins and Peptides Market Competitive Situation and Trends

2.8.1 Global Oral Proteins and Peptides Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Oral Proteins and Peptides Players Market Share by Revenue

2.8.3 Global Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Oral Proteins and Peptides Market Scenario by Region

3.1 Global Oral Proteins and Peptides Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Oral Proteins and Peptides Sales by Region: 2020-2031

3.2.1 Global Oral Proteins and Peptides Sales by Region: 2020-2025

3.2.2 Global Oral Proteins and Peptides Sales by Region: 2026-2031

3.3 Global Oral Proteins and Peptides Revenue by Region: 2020-2031

3.3.1 Global Oral Proteins and Peptides Revenue by Region: 2020-2025

3.3.2 Global Oral Proteins and Peptides Revenue by Region: 2026-2031

3.4 North America Oral Proteins and Peptides Market Facts & Figures by Country

3.4.1 North America Oral Proteins and Peptides Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Oral Proteins and Peptides Sales by Country (2020-2031)

3.4.3 North America Oral Proteins and Peptides Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Oral Proteins and Peptides Market Facts & Figures by Country

3.5.1 Europe Oral Proteins and Peptides Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Oral Proteins and Peptides Sales by Country (2020-2031)

3.5.3 Europe Oral Proteins and Peptides Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Oral Proteins and Peptides Market Facts & Figures by Region

3.6.1 Asia Pacific Oral Proteins and Peptides Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Oral Proteins and Peptides Sales by Region (2020-2031)

3.6.3 Asia Pacific Oral Proteins and Peptides Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Oral Proteins and Peptides Market Facts & Figures by Country

3.7.1 Latin America Oral Proteins and Peptides Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Oral Proteins and Peptides Sales by Country (2020-2031)

3.7.3 Latin America Oral Proteins and Peptides Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Oral Proteins and Peptides Market Facts & Figures by Country

3.8.1 Middle East and Africa Oral Proteins and Peptides Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Oral Proteins and Peptides Sales by Country (2020-2031)

3.8.3 Middle East and Africa Oral Proteins and Peptides Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Oral Proteins and Peptides Sales by Type (2020-2031)

4.1.1 Global Oral Proteins and Peptides Sales by Type (2020-2025)

4.1.2 Global Oral Proteins and Peptides Sales by Type (2026-2031)

4.1.3 Global Oral Proteins and Peptides Sales Market Share by Type (2020-2031)

4.2 Global Oral Proteins and Peptides Revenue by Type (2020-2031)

4.2.1 Global Oral Proteins and Peptides Revenue by Type (2020-2025)

4.2.2 Global Oral Proteins and Peptides Revenue by Type (2026-2031)

4.2.3 Global Oral Proteins and Peptides Revenue Market Share by Type (2020-2031)

4.3 Global Oral Proteins and Peptides Price by Type (2020-2031)

5 Segment by Application

5.1 Global Oral Proteins and Peptides Sales by Application (2020-2031)

5.1.1 Global Oral Proteins and Peptides Sales by Application (2020-2025)

5.1.2 Global Oral Proteins and Peptides Sales by Application (2026-2031)

5.1.3 Global Oral Proteins and Peptides Sales Market Share by Application (2020-2031)

5.2 Global Oral Proteins and Peptides Revenue by Application (2020-2031)

5.2.1 Global Oral Proteins and Peptides Revenue by Application (2020-2025)

5.2.2 Global Oral Proteins and Peptides Revenue by Application (2026-2031)

5.2.3 Global Oral Proteins and Peptides Revenue Market Share by Application (2020-2031)

5.3 Global Oral Proteins and Peptides Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Ironwood & Allergan

6.1.1 Ironwood & Allergan Company Information

6.1.2 Ironwood & Allergan Description and Business Overview

6.1.3 Ironwood & Allergan Oral Proteins and Peptides Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Ironwood & Allergan Oral Proteins and Peptides Product Portfolio

6.1.5 Ironwood & Allergan Recent Developments/Updates

6.2 Novo Nordisk

6.2.1 Novo Nordisk Company Information

6.2.2 Novo Nordisk Description and Business Overview

6.2.3 Novo Nordisk Oral Proteins and Peptides Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Novo Nordisk Oral Proteins and Peptides Product Portfolio

6.2.5 Novo Nordisk Recent Developments/Updates

6.3 Synergy Pharmaceuticals （Salix）

6.3.1 Synergy Pharmaceuticals （Salix） Company Information

6.3.2 Synergy Pharmaceuticals （Salix） Description and Business Overview

6.3.3 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product Portfolio

6.3.5 Synergy Pharmaceuticals （Salix） Recent Developments/Updates

6.4 Novartis

6.4.1 Novartis Company Information

6.4.2 Novartis Description and Business Overview

6.4.3 Novartis Oral Proteins and Peptides Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Novartis Oral Proteins and Peptides Product Portfolio

6.4.5 Novartis Recent Developments/Updates

6.5 Chiasma (Amryt Pharma)

6.5.1 Chiasma (Amryt Pharma) Company Information

6.5.2 Chiasma (Amryt Pharma) Description and Business Overview

6.5.3 Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Chiasma (Amryt Pharma) Oral Proteins and Peptides Product Portfolio

6.5.5 Chiasma (Amryt Pharma) Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Oral Proteins and Peptides Industry Chain Analysis

7.2 Oral Proteins and Peptides Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Oral Proteins and Peptides Production Mode & Process Analysis

7.4 Oral Proteins and Peptides Sales and Marketing

7.4.1 Oral Proteins and Peptides Sales Channels

7.4.2 Oral Proteins and Peptides Distributors

7.5 Oral Proteins and Peptides Customer Analysis

8 Oral Proteins and Peptides Market Dynamics

8.1 Oral Proteins and Peptides Industry Trends

8.2 Oral Proteins and Peptides Market Drivers

8.3 Oral Proteins and Peptides Market Challenges

8.4 Oral Proteins and Peptides Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Novo Nordisk

Novartis

Synergy Pharmaceuticals （Salix）

Ironwood & Allergan

Chiasma (Amryt Pharma)

List of Tables

Table 1. Global Oral Proteins and Peptides Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Oral Proteins and Peptides Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Oral Proteins and Peptides Market Competitive Situation by Manufacturers in 2024

Table 4. Global Oral Proteins and Peptides Sales (Kg) of Key Manufacturers (2020-2025)

Table 5. Global Oral Proteins and Peptides Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Oral Proteins and Peptides Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Oral Proteins and Peptides Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Oral Proteins and Peptides Average Price (US$/Mg) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Oral Proteins and Peptides, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Oral Proteins and Peptides, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Oral Proteins and Peptides, Product Type & Application

Table 12. Global Key Manufacturers of Oral Proteins and Peptides, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Oral Proteins and Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Proteins and Peptides as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Oral Proteins and Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Oral Proteins and Peptides Sales by Region (2020-2025) & (Kg)

Table 18. Global Oral Proteins and Peptides Sales Market Share by Region (2020-2025)

Table 19. Global Oral Proteins and Peptides Sales by Region (2026-2031) & (Kg)

Table 20. Global Oral Proteins and Peptides Sales Market Share by Region (2026-2031)

Table 21. Global Oral Proteins and Peptides Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Oral Proteins and Peptides Revenue Market Share by Region (2020-2025)

Table 23. Global Oral Proteins and Peptides Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Oral Proteins and Peptides Revenue Market Share by Region (2026-2031)

Table 25. North America Oral Proteins and Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)

Table 27. North America Oral Proteins and Peptides Sales by Country (2026-2031) & (Kg)

Table 28. North America Oral Proteins and Peptides Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Oral Proteins and Peptides Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Oral Proteins and Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)

Table 32. Europe Oral Proteins and Peptides Sales by Country (2026-2031) & (Kg)

Table 33. Europe Oral Proteins and Peptides Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Oral Proteins and Peptides Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Oral Proteins and Peptides Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Oral Proteins and Peptides Sales by Region (2020-2025) & (Kg)

Table 37. Asia Pacific Oral Proteins and Peptides Sales by Region (2026-2031) & (Kg)

Table 38. Asia Pacific Oral Proteins and Peptides Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Oral Proteins and Peptides Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Oral Proteins and Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)

Table 42. Latin America Oral Proteins and Peptides Sales by Country (2026-2031) & (Kg)

Table 43. Latin America Oral Proteins and Peptides Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Oral Proteins and Peptides Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Oral Proteins and Peptides Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Oral Proteins and Peptides Sales by Country (2020-2025) & (Kg)

Table 47. Middle East and Africa Oral Proteins and Peptides Sales by Country (2026-2031) & (Kg)

Table 48. Middle East and Africa Oral Proteins and Peptides Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Oral Proteins and Peptides Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Oral Proteins and Peptides Sales (Kg) by Type (2020-2025)

Table 51. Global Oral Proteins and Peptides Sales (Kg) by Type (2026-2031)

Table 52. Global Oral Proteins and Peptides Sales Market Share by Type (2020-2025)

Table 53. Global Oral Proteins and Peptides Sales Market Share by Type (2026-2031)

Table 54. Global Oral Proteins and Peptides Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Oral Proteins and Peptides Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Oral Proteins and Peptides Revenue Market Share by Type (2020-2025)

Table 57. Global Oral Proteins and Peptides Revenue Market Share by Type (2026-2031)

Table 58. Global Oral Proteins and Peptides Price (US$/Mg) by Type (2020-2025)

Table 59. Global Oral Proteins and Peptides Price (US$/Mg) by Type (2026-2031)

Table 60. Global Oral Proteins and Peptides Sales (Kg) by Application (2020-2025)

Table 61. Global Oral Proteins and Peptides Sales (Kg) by Application (2026-2031)

Table 62. Global Oral Proteins and Peptides Sales Market Share by Application (2020-2025)

Table 63. Global Oral Proteins and Peptides Sales Market Share by Application (2026-2031)

Table 64. Global Oral Proteins and Peptides Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Oral Proteins and Peptides Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Oral Proteins and Peptides Revenue Market Share by Application (2020-2025)

Table 67. Global Oral Proteins and Peptides Revenue Market Share by Application (2026-2031)

Table 68. Global Oral Proteins and Peptides Price (US$/Mg) by Application (2020-2025)

Table 69. Global Oral Proteins and Peptides Price (US$/Mg) by Application (2026-2031)

Table 70. Ironwood & Allergan Company Information

Table 71. Ironwood & Allergan Description and Business Overview

Table 72. Ironwood & Allergan Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)

Table 73. Ironwood & Allergan Oral Proteins and Peptides Product

Table 74. Ironwood & Allergan Recent Developments/Updates

Table 75. Novo Nordisk Company Information

Table 76. Novo Nordisk Description and Business Overview

Table 77. Novo Nordisk Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)

Table 78. Novo Nordisk Oral Proteins and Peptides Product

Table 79. Novo Nordisk Recent Developments/Updates

Table 80. Synergy Pharmaceuticals （Salix） Company Information

Table 81. Synergy Pharmaceuticals （Salix） Description and Business Overview

Table 82. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)

Table 83. Synergy Pharmaceuticals （Salix） Oral Proteins and Peptides Product

Table 84. Synergy Pharmaceuticals （Salix） Recent Developments/Updates

Table 85. Novartis Company Information

Table 86. Novartis Description and Business Overview

Table 87. Novartis Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)

Table 88. Novartis Oral Proteins and Peptides Product

Table 89. Novartis Recent Developments/Updates

Table 90. Chiasma (Amryt Pharma) Company Information

Table 91. Chiasma (Amryt Pharma) Description and Business Overview

Table 92. Chiasma (Amryt Pharma) Oral Proteins and Peptides Sales (Kg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)

Table 93. Chiasma (Amryt Pharma) Oral Proteins and Peptides Product

Table 94. Chiasma (Amryt Pharma) Recent Developments/Updates

Table 95. Key Raw Materials Lists

Table 96. Raw Materials Key Suppliers Lists

Table 97. Oral Proteins and Peptides Distributors List

Table 98. Oral Proteins and Peptides Customers List

Table 99. Oral Proteins and Peptides Market Trends

Table 100. Oral Proteins and Peptides Market Drivers

Table 101. Oral Proteins and Peptides Market Challenges

Table 102. Oral Proteins and Peptides Market Restraints

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

Table 106. Authors List of This Report

List of Figures

Figure 1. Product Picture of Oral Proteins and Peptides

Figure 2. Global Oral Proteins and Peptides Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Oral Proteins and Peptides Market Share by Type: 2024 & 2031

Figure 4. Linaclotide Product Picture

Figure 5. Insulin Product Picture

Figure 6. Plecanatide Product Picture

Figure 7. Cyclosporine Product Picture

Figure 8. Octreotide Product Picture

Figure 9. Global Oral Proteins and Peptides Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Oral Proteins and Peptides Market Share by Application: 2024 & 2031

Figure 11. Gastric & Digestive Disorders

Figure 12. Bone Diseases

Figure 13. Diabetes

Figure 14. Hormonal Disorders

Figure 15. Global Oral Proteins and Peptides Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Oral Proteins and Peptides Market Size (2020-2031) & (US$ Million)

Figure 17. Global Oral Proteins and Peptides Sales (2020-2031) & (Kg)

Figure 18. Global Oral Proteins and Peptides Average Price (US$/Mg) & (2020-2031)

Figure 19. Oral Proteins and Peptides Report Years Considered

Figure 20. Oral Proteins and Peptides Sales Share by Manufacturers in 2024

Figure 21. Global Oral Proteins and Peptides Revenue Share by Manufacturers in 2024

Figure 22. Global 5 and 10 Largest Oral Proteins and Peptides Players: Market Share by Revenue in Oral Proteins and Peptides in 2024

Figure 23. Oral Proteins and Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 24. Global Oral Proteins and Peptides Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 25. North America Oral Proteins and Peptides Sales Market Share by Country (2020-2031)

Figure 26. North America Oral Proteins and Peptides Revenue Market Share by Country (2020-2031)

Figure 27. United States Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Canada Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Europe Oral Proteins and Peptides Sales Market Share by Country (2020-2031)

Figure 30. Europe Oral Proteins and Peptides Revenue Market Share by Country (2020-2031)

Figure 31. Germany Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. France Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. U.K. Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Italy Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Russia Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Asia Pacific Oral Proteins and Peptides Sales Market Share by Region (2020-2031)

Figure 37. Asia Pacific Oral Proteins and Peptides Revenue Market Share by Region (2020-2031)

Figure 38. China Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Japan Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. South Korea Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. India Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Australia Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. China Taiwan Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Indonesia Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Thailand Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Malaysia Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Oral Proteins and Peptides Sales Market Share by Country (2020-2031)

Figure 48. Latin America Oral Proteins and Peptides Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Oral Proteins and Peptides Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Oral Proteins and Peptides Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. UAE Oral Proteins and Peptides Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Oral Proteins and Peptides by Type (2020-2031)

Figure 58. Global Revenue Market Share of Oral Proteins and Peptides by Type (2020-2031)

Figure 59. Global Oral Proteins and Peptides Price (US$/Mg) by Type (2020-2031)

Figure 60. Global Sales Market Share of Oral Proteins and Peptides by Application (2020-2031)

Figure 61. Global Revenue Market Share of Oral Proteins and Peptides by Application (2020-2031)

Figure 62. Global Oral Proteins and Peptides Price (US$/Mg) by Application (2020-2031)

Figure 63. Oral Proteins and Peptides Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Oral Peptide Drugs Market Research Report 2024

Global Protein and Peptide Therapeutics Market Research Report 2025

Peptide Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Synthesis Polypeptide Drugs Market Insights Forecast to 2030

Peptide based Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Protein Peptide Drug Market Research Report 2024

Global Peptide Based Cancer Therapeutics Market Research Report 2024

Global Peptide Therapy Market Research Report 2025

Global Peptide and Oligonucleotide Drugs Market Research Report 2024

Global Chemosynthetic Polypeptide Drugs Market Research Report 2024

Global Oral Peptide Therapy Market Research Report 2025

Global Oral Peptide Drug Market Research Report 2025

Global Peptide based Generics Market Research Report 2024

Peptide based Injectable Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Injection Peptide Drug Market Research Report 2025

Injectable Peptides Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Therapeutic Proteins and Oral Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Polypeptide Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Protein Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions